Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
TCT ID 3: Treatment With Icosapent Ethyl to Reduce Ischemic Events in ...
REDUCTION IN HEART FAILURE WITH ICOSAPENT ETHYL: INSIGHTS FROM REDUCE ...
Significant Reduction in ST-Elevation MI With Icosapent Ethyl in REDUCE ...
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients ...
(PDF) Evidence for pharmacological interventions to reduce ...
REDUCE-IT Trial: A 5-question Quiz
ADA20-Presentation-Slides-REDUCE-IT-DIABETES.pdf
Icosapent Ethyl Effective in Lowering Cardiovascular Risk
The REDUCE-IT Trial: A New Hope for Heart Health – Premier Catch
Icosapent ethyl: evidence and guidelines recommendations | PDF
Rationale and design of REDUCE‐IT: Reduction of Cardiovascular Events ...
Generalizability of the REDUCE-IT trial and cardiovascular outcomes ...
REDUCE-IT: Cardiovascular Risk Reduction With Icosapent Ethyl for ...
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without ...
(PDF) Profound reductions in first and total cardiovascular events with ...
(PDF) Rationale and design of REDUCE-IT: Reduction of Cardiovascular ...
Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention ...
REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent ...
Secondary analysis of the REDUCE‐IT trial: Cardiovascular outcomes with ...
Statin Plus Icosapent for Reducing Cardiovascular Disease | BioSerendipity
REDUCE-IT: Cardiovascular Risk Reduction with Icosapent Ethyl for ...
Benefits of icosapent ethyl for enhancing residual cardiovascular risk ...
Vascepa® (icosapent ethyl) Showed 30% Reduction in Total Cardiovascular ...
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients ...
SIGNIFICANT CARDIOVASCULAR BENEFITS OF ICOSAPENT ETHYL FROM REDUCE-IT ...
(PDF) Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in ...
#VisualAbstract: Cardiovascular Risk Reduction with Icosapent Ethyl for ...
Results from the Vascepa® (icosapent ethyl) cardiovascular outcomes ...
REDUCE-IT REVASC Suggests Icosapent Ethyl Cuts Rate of Revascularizations
(PDF) Cardiovascular Benefits of Icosapent Ethyl in Patients With and ...
Cardiovascular Risk Reduction with Icosapent Ethyl for ...
(PDF) Icosapent ethyl following acute coronary syndrome: the REDUCE-IT ...
Full article: Impact of Expanded FDA Indication for Icosapent Ethyl On ...
二十碳五烯酸乙酯心血管结局研究解读：REDUCE-IT研究 - 知乎
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Eviden ...
Landmark – REDUCE-IT: Icosapent ethyl reduces cardiovascular risk even ...
Figure 3 from Profound reductions in first and total cardiovascular ...
Generalizability of the REDUCE-IT Trial in Patients With Stable ...
Treatment of hypertriglyceridaemia with icosapent ethyl in patients ...
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial ...
Full article: The case for adding eicosapentaenoic acid (icosapent ...
Generalizability of the REDUCE-IT trial to South Asians with ...
REDUCE-IT PCI Details Benefits of Icosapent Ethyl in Patients with ...
Icosapent Ethyl for the Prevention of Cardiovascular Events - European ...
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density ...
REDUCE-IT (Vascepa) vs. STRENGTH (Epanova)- Why the Different Results ...
Cost‐Effectiveness of Icosapent Ethyl in REDUCE‐IT USA: Results From ...
Épisode 21 : Étude REDUCE-IT - BaladoCritique : Club de lecture médical ...
Cardiology Community Heartened by REDUCE-IT Trial Results - Brigham ...
Effectiveness of icosapent ethyl on first and total cardiovascular ...
Mechanisms behind the CV benefits in the REDUCE-IT trial. The REDUCE-IT ...
VASCEPA® (icosapent ethyl) Shows Significant Reduction in Coronary ...
(PDF) Reduction in Revascularization with Icosapent Ethyl: Insights ...
Benefit of icosapent ethyl across types and sizes of myocardial ...
(PDF) Residual risk in cardiac rehab: can we REDUCE-IT MORE ...
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial ...
Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT ...
Full article: Icosapent ethyl for reduction of persistent ...
Integrating icosapent ethyl in clinical practice: which patients will ...
REDUCE-IT: Icosapent Ethyl Shows Significant Reduction in Coronary ...
(PDF) Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An ...
Amarin Posts New Data Showing Benefit of Vascepa In High-Risk Patients ...
REDUCE-IT Trial Proves EPA Lowers Cardiovascular Risk – Revolution ...
Benefits of Icosapent Ethyl Across the Range of Kidney Function in ...
(PDF) Potential Effects of Icosapent Ethyl on Cardiovascular Outcomes ...
(PDF) Icosapent ethyl for reduction of persistent cardiovascular risk ...
REDUCE-IT: CV Outcomes With Icosapent Ethyl by Baseline LDL-C - YouTube
Icosapent Ethyl for Hypertriglyceridemia: Insights From the REDUCE-IT ...
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of ...
Abstract 57: Reduction in Ischemic Stroke With Icosapent Ethyl ...
Abstract 12542: Effectiveness of Icosapent Ethyl on First and Total ...
New REDUCE-IT analysis shows benefits of icosapent ethyl in patients ...
Reduction of Revascularization in Patients with Hypertriglyceridemia ...
(PDF) Benefits of Icosapent Ethyl Across the Range of Kidney Function ...
Med.IQ - 🫀 O EASD 2025 trouxe novas evidências sobre o Icosapent Ethyl ...
CVD & Vascepa EPA Fish Oil 4000 mg Daily - "Reduction of Cardiovascular ...
Reduction in Revascularization With Icosapent Ethyl: Insights From ...
REDUCE-IT PRIOR MI结果重磅发布，IPE心血管获益再添新证｜ESC 2021 IPE系列报道（一） - 知乎
